Daily non-political popular news in brief.

Support for chromosomal theory of cancer found in cancers' development of drug resistance

Most cancer researchers are convinced that cancer results from a handful of genetic mutations that kick a cell into uncontrolled growth. UC Berkeley genetics researcher Peter Duesberg disagrees, and finds support for his "chromosomal" theory of cancer in the development of drug resistance by many cancers. While his theory implies their is no magic bullet against cancer, it does provide ways to detect cancer at an early stage.

Read more »

Keywords: support, chromosomal, theory, cancer, cancers, development, drug, resistance

« Previous | Next »

Similar news on "Support for chromosomal theory of cancer found in cancers' development of drug resistance":

1. Ireland Cancer Center researchers advance lung cancer treatment
   04-23-2007 · EurekAlert!
   Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
   Similar news · Read more »
   
2. Researchers shed light on mechanism of action used by anti-cancer drug
   06-11-2007 · EurekAlert!
   Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.
   Similar news · Read more »
   
3. DMP1 deletion cooperates with oncogenic K-ras in lung cancer
   10-15-2007 · EurekAlert!
   Scientists have identified the transcription factor DMP1 as a pivotal tumor suppressor for both human and mouse lung cancers, especially in carcinomas that exhibit intact Arf-p53 pathways. The research, published by Cell Press in the October 2007 issue of Cancer Cell, may lead to development of new drug therapies for lung cancer.
   Similar news · Read more »
   
4. Finasteride unlikely to induce high grade prostate cancers
   09-11-2007 · EurekAlert!
   An increase in high-grade prostate cancer among men taking the drug finasteride is likely caused by an increased detection of cancers, and not by the development of more high-grade cancers, according to two studies published online September 11 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
5. Tailored treatments: Promising designer drug provides new insight into cancer biology
   11-13-2006 · EurekAlert!
   Scientists are making progress toward unraveling the molecular mysteries that underlie cancer progression and treatment resistance. Two studies in the November 2006 issue of the journal Cancer Cell, published by Cell Press, provide mechanistic details that may explain why the small-molecule chemical ABT-737 is emerging as a unique and effective anticancer agent.
   Similar news · Read more »
   
6. Leukemia drug turns mini-molecules up, cancer genes down
   03-01-2007 · EurekAlert!
   New research shows that a form of vitamin A used to treat acute promyelocytic leukemia induces changes in an unusual class of small molecules called microRNAs (miRNAs) in the leukemic cells. The study also shows that three of these miRNAs inhibit the action of two genes important for cancer development, helping to explain how the drug works.
   Similar news · Read more »
   
7. Horvitz urges support for basic science
   04-26-2007 · Massachusetts Institute of Technology (MIT)
   H. Robert Horvitz, the David H. Koch Professor of Cancer Biology and recipient of the Nobel Prize, delivered the 35th annual Killian Award lecture April 24. Horvitz spoke on "Worms, Life and Death: Cell Suicide in Development and Disease."
   Similar news · Read more »
   
8. Study reveals a key to blood vessel growth and possible drug target
   10-14-2007 · EurekAlert!
   Researchers have identified a molecular pathway that plays a critical role in the growth of blood vessels. The finding not only offers an important insight into the development of the vascular system during embryonic development but suggests a potential target for inhibiting the blood vessels that fuel cancers, diabetic eye complications and atherosclerosis, the researchers say.
   Similar news · Read more »
   
9. Cancer Drug May Be Remedy For Rheumatoid Arthritis, Study Finds
   09-30-2006 · ScienceDaily
   The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis, according to a team of researchers at the Stanford University School of Medicine.
   Similar news · Read more »
   
10. Study Reveals Mechanism For Cancer-drug Resistance
    10-11-2006 · ScienceDaily
    Using the worm Caenorhabditis elegans, researchers at UT Southwestern Medical Center have discovered a mechanism by which cancer cells become resistant to a specific class of drugs.
    Similar news · Read more »